Literature DB >> 9371530

Immunological abnormalities in splenic marginal zone cell lymphoma.

H Murakami1, H Irisawa, T Saitoh, T Matsushima, J Tamura, M Sawamura, M Karasawa, Y Hosomura, M Kojima.   

Abstract

The clinical features of patients with splenic marginal zone cell lymphoma (SMZCL) have rarely been reported. In the present study, immunological abnormalities, particularly hematological abnormalities, observed in SMZCL were described. Autoimmune hemolytic anemia, immune thrombocytopenia, and appearance of lupus anticoagulant were observed in 2 of 3 patients with SMZCL. Other abnormal data including monoclonal gammopathy and cold agglutinin were also observed in 2 of the 3 patients. Immunological abnormalities may be characteristic complications in patients with SMZCL and must be followed carefully, since they may be a reliable marker of this type of lymphoma activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371530     DOI: 10.1002/(sici)1096-8652(199711)56:3<173::aid-ajh7>3.0.co;2-v

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Rapid improvement of massive bloody pleural effusion after splenectomy for splenic marginal zone lymphoma.

Authors:  Miyuki Okuda; Nobuya Tanaka; Makoto Kashio; Noriyuki Sagara; Katsuyuki Aozasa; Yoshinari Okuda; Izuo Tsuyuguchi
Journal:  BMJ Case Rep       Date:  2009-04-14

2.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

3.  Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.

Authors:  Luís Alberto de Pádua Covas Lage; Felipe Faganelli Caboclo Dos Santos; Débora Levy; Frederico Rafael Moreira; Samuel Campanelli Freitas Couto; Hebert Fabrício Culler; Renata de Oliveira Costa; Vanderson Rocha; Juliana Pereira
Journal:  BMC Cancer       Date:  2020-08-03       Impact factor: 4.430

4.  Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.

Authors:  Minodora Onisâi; Ana-Maria Vlădăreanu; Adriana Nica; Andreea Spînu; Mihaela Găman; Horia Bumbea; Irina Voican; Iuliana Iordan; Adrian Alexandru; Mihnea Zdrenghea; Daniela Gheorghita; Sebastian Grădinaru
Journal:  Medicina (Kaunas)       Date:  2019-12-27       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.